166 related articles for article (PubMed ID: 18277387)
1. Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats.
Yoshioka K; Wakino S; Homma K; Kanda T; Tatematsu S; Hasegawa K; Sugano N; Ito O; Omata K; Saruta T; Hayashi K
Obesity (Silver Spring); 2008 May; 16(5):965-71. PubMed ID: 18277387
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
Samadfam R; Awori M; Bénardeau A; Bauss F; Sebokova E; Wright M; Smith SY
J Endocrinol; 2012 Feb; 212(2):179-86. PubMed ID: 22062085
[TBL] [Abstract][Full Text] [Related]
3. Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats.
Zhou Y; Huang H; Chang HH; Du J; Wu JF; Wang CY; Wang MH
J Pharmacol Exp Ther; 2006 Apr; 317(1):11-8. PubMed ID: 16339392
[TBL] [Abstract][Full Text] [Related]
4. PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats.
Zhao X; Li LY
Am J Nephrol; 2008; 28(4):598-606. PubMed ID: 18277067
[TBL] [Abstract][Full Text] [Related]
5. Inability to upregulate cytochrome P450 4A and 2C causes salt sensitivity in young Sprague-Dawley rats.
Sankaralingam S; Desai KM; Glaeser H; Kim RB; Wilson TW
Am J Hypertens; 2006 Nov; 19(11):1174-80. PubMed ID: 17070431
[TBL] [Abstract][Full Text] [Related]
6. Rofecoxib decreases renal injury in obese Zucker rats.
Dey A; Maric C; Kaesemeyer WH; Zaharis CZ; Stewart J; Pollock JS; Imig JD
Clin Sci (Lond); 2004 Dec; 107(6):561-70. PubMed ID: 15307815
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
Oliveira AC; Bertollo CM; Rocha LT; Nascimento EB; Costa KA; Coelho MM
Eur J Pharmacol; 2007 Apr; 561(1-3):194-201. PubMed ID: 17343847
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.
Ye Y; Nishi SP; Manickavasagam S; Lin Y; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):43-53. PubMed ID: 17643887
[TBL] [Abstract][Full Text] [Related]
9. Ovariectomy, but not estrogen deficiency, increases CYP4A modulation of alpha(1)-adrenergic vasoconstriction in aging female rats.
Berezan DJ; Xu Y; Falck JR; Kundu AP; Davidge ST
Am J Hypertens; 2008 Jun; 21(6):685-90. PubMed ID: 18437124
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of peroxisome proliferator activator receptor (PPAR)-α and -γ ligands against methotrexate-induced nephrotoxicity.
Ibrahim MA; El-Sheikh AA; Khalaf HM; Abdelrahman AM
Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):130-7. PubMed ID: 24521009
[TBL] [Abstract][Full Text] [Related]
11. Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet.
Zhou Y; Lin S; Chang HH; Du J; Dong Z; Dorrance AM; Brands MW; Wang MH
Am J Hypertens; 2005 Apr; 18(4 Pt 1):530-7. PubMed ID: 15831364
[TBL] [Abstract][Full Text] [Related]
12. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.
Birnbaum Y; Long B; Qian J; Perez-Polo JR; Ye Y
Basic Res Cardiol; 2011 May; 106(3):431-46. PubMed ID: 21360043
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone regulates ENaC and Na-K-2Cl cotransporter (NKCC2) abundance in the obese Zucker rat.
Riazi S; Khan O; Tiwari S; Hu X; Ecelbarger CA
Am J Nephrol; 2006; 26(3):245-57. PubMed ID: 16757903
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
Shigeto T; Yokoyama Y; Xin B; Mizunuma H
Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
[TBL] [Abstract][Full Text] [Related]
16. The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.
Zanchi A; Perregaux C; Maillard M; Cefai D; Nussberger J; Burnier M
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1228-34. PubMed ID: 16835400
[TBL] [Abstract][Full Text] [Related]
17. The effects of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation.
Li D; Chen K; Sinha N; Zhang X; Wang Y; Sinha AK; Romeo F; Mehta JL
Cardiovasc Res; 2005 Mar; 65(4):907-12. PubMed ID: 15721871
[TBL] [Abstract][Full Text] [Related]
18. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
[TBL] [Abstract][Full Text] [Related]
19. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats.
Lahiri S; Sen T; Palit G
Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone, a PPAR-gamma ligand inhibited the nicotinamide-streptozotocin induced sperm abnormalities in type-2 diabetic Wistar rats.
Rabbani SI; Devi K; Khanam S
Pak J Pharm Sci; 2010 Jul; 23(3):326-31. PubMed ID: 20566448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
